|
HS Code |
390177 |
| Generic Name | Propranolol Hydrochloride |
| Brand Names | Inderal, Inderal LA, InnoPran XL |
| Drug Class | Non-selective beta-blocker |
| Dosage Forms | Tablet, extended-release capsule, oral solution, injectable |
| Route Of Administration | Oral, intravenous |
| Mechanism Of Action | Blocks beta-adrenergic receptors |
| Indications | Hypertension, angina pectoris, arrhythmias, migraine prevention, tremors |
| Contraindications | Asthma, severe bradycardia, uncompensated heart failure |
| Common Side Effects | Bradycardia, fatigue, dizziness, nausea |
| Pregnancy Category | C |
| Legal Status | Prescription only |
| Half Life | 3 to 6 hours |
| Molecular Formula | C16H21NO2·HCl |
| Storage Conditions | Store at 20–25°C (68–77°F), protect from light and moisture |
| Atc Code | C07AA05 |
As an accredited Propranolol Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A white, opaque plastic bottle containing 100 tablets of Propranolol Hydrochloride, each tablet clearly labeled with dosage and manufacturer details. |
| Shipping | Propranolol Hydrochloride should be shipped in tightly sealed, properly labeled containers, protected from moisture and light. It must comply with all relevant regulations regarding hazardous materials. Ensure the package includes appropriate safety data documentation. Temperature controls are recommended to avoid decomposition, and it should be kept away from incompatible substances during transit. |
| Storage | Propranolol Hydrochloride should be stored in a tightly closed container at controlled room temperature, typically between 20°C to 25°C (68°F to 77°F). It must be kept away from moisture, heat, and direct light. The storage area should be secure, dry, and well-ventilated to maintain chemical stability and prevent contamination or degradation. |
Competitive Propranolol Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Making Propranolol Hydrochloride isn’t a simple matter of mixing powders and sealing drums. Behind every kilogram, there’s a plant filled with careful operators, analytical chemists, and technicians who have watched this compound roll out of reactors for years. Our product comes as a white to off-white crystalline powder, commonly known under the model BP/EP/USP, with purity levels topping 99%. We don’t reach these levels by accident or by relying on shortcuts. The target is simple — every batch has to clear its HPLC, GC, and other quality tests before it moves from the process department to the warehouse.
In our own experience, even the smallest issue shows up during scale-up. Laboratory yields don’t always translate cleanly into ten-ton runs, but missing a parameter is out of the question. Consistency means controlling the amine and epoxide reaction, keeping moisture in check, validating every solvent lot, and matching the particle size distribution for downstream use in tablets or injectables. When a batch reads off in color or purity, all eyes turn to the reactor logbook.
API customers look past the headline purity. Particle size may dominate conversations with granulation-based formulators, but it is only part of the picture. Microbial contamination and heavy metal levels fall under the spotlight as well. Routinely, lots ship with no more than a few ppm of heavy metals, and a bioburden measure that fits under the regulatory threshold for parenteral grade. Moisture content sits around 0.5% by KF titration, and we monitor residual solvents down to well below ICH Q3C thresholds.
Propranolol Hydrochloride in the BP, EP, and USP standards share the chemical backbone, but our clients require their own paperwork trail: a full CoA, residual solvents sheet, and if needed, a DMF cross-reference. All regulatory filings are maintained in active status, ready for auditing or regulatory queries at any time. Our in-house QC uses both compendial and non-compendial testing. For example, certain clients still request a UV-spectrophotometric fingerprint, even as HPLC or LC-MS take over the analysis.
You don’t find the secrets to successful manufacturing in an equipment manual. Making quality Propranolol Hydrochloride is equal parts technical expertise and team experience. During the coupling process, temperature spikes or pH drift can destroy a whole lot’s worth of raw materials. The team routinely tracks reaction kinetics, stirs in deionized water at just the right stage, and doesn’t move on to drying until the intermediate hits specification. Our operators know from experience how a shift in 5°C during crystallization can alter yield and impurity profiles.
Packaging lines have their own challenges. We use pharmaceutical-grade HDPE drums lined with LDPE bags, and staff don’t hesitate to reject a drum that smells unusual or shows even faint yellowing. APIs such as Propranolol Hydrochloride need a stable, dry, and cool environment to stay within spec beyond the shelf-life listed on paper. Real-world usage in bulk shipping containers faces temperature swings and humidity, so our logistics process lines everything with desiccant packs and full monitoring tags.
Scale brings its own form of pressure. As demand for Propranolol Hydrochloride grew, producing smaller GMP batches for niche customers seemed easy. With global customers ordering several tons in a single PO, precision at every step becomes essential. The temptation to cut corners never wins against the risk of a market recall. We respect each audit, not just from agencies like USFDA or EDQM, but from our own clients' scientists who walk the production floors and check our SOPs line by line.
We’ve learned to build flexibility into our plants, running multiple scales in parallel, from 500-gram pilot batches for R&D up to industrial reactors where throughput, not experimentation, dominates. Process engineers and QA staff run their own checks, independent from sales or executive roles. All deviation reports and CAPAs go back to root-cause analysis, sometimes at the cost of delaying a shipment rather than risking a compliance incident.
Formulators in the medical industry depend on Propranolol Hydrochloride primarily for its established role in treating cardiovascular conditions, including hypertension and arrhythmias, and more recently, for uses in migraine prevention, essential tremor, and anxiety symptoms. Being on the frontline with customers, we’ve noticed many end-formulators develop new delivery systems. Some require a microfine powder for direct compressibility, while others want granular forms for slow-release tablets.
Our engagement doesn’t end with the shipment. We supply samples to research teams developing extended release capsules, pediatric suspensions, and injectable solutions. With biowaivers and novel dosage technologies evolving, specification tweaking happens regularly. Each adjustment in particle size distribution, bulk density, or trace residual solvent reflects the practical needs of formulators designing better therapies in the field.
Doctors rely on a toolkit of beta-blockers in their practice, but Propranolol Hydrochloride has a broader application and history of safety, making it the go-to for non-selective beta-blockade. From our perspective as manufacturers, the chemical purity requires closer attention than some alternatives like Atenolol, which can tolerate higher levels of moisture or certain organic byproducts. Propranolol Hydrochloride, in contrast, reacts more aggressively with ambient moisture, making plant humidity controls critical.
Formulators also run into the issue of solubility. This active ingredient dissolves readily in water, which gives it flexibility in both oral and injectable dosage forms. Bisoprolol and Metoprolol offer more selectivity at the receptor level, but Propranolol Hydrochloride leads for indications needing non-selective action. For manufacturers, the synthetic steps for Propranolol Hydrochloride draw on more established raw material supply chains, helping keep costs steady and avoiding periodic shortages seen with less frequently prescribed APIs.
Safety doesn’t stop at process design or batch release testing. Every delivery of raw materials brings its own set of risks. We verify provenance for starting materials, ensure all excipients pass our supplier audits, and track raw material lots digitally. Once the process runs, sample retention becomes the norm — not an option. Each batch yields three retained samples, stored in humidity and temperature-controlled environments for future reference.
Our team has invested in staff training for handling potent APIs, personal protective measures, and spill response. These aren’t empty words on a safety policy sheet. Every incident teaches something — whether it’s a minor spill of intermediate, or handling a customer’s temperature excursion concern during shipping. Clients care about traceability, so every movement from receipt of raw material to delivery of finished product records by batch, timestamp, and dedicated operator within our MES.
We face regulatory inspections regularly, some announced and some on short notice. Inspectors care less about posturing and more about evidence. Each production log, SOP version, and change control justification needs to be clear, signed, and accessible. We’ve seen first-hand how lack of training or documentation can cause a batch to fall out of compliance. Regulatory bodies frequently ask about replicable analytical validation, cleaning procedures, and environmental monitoring.
Our site holds certifications under cGMP as dictated by ICH Q7, follows strict documentation per 21 CFR Part 211, and conducts yearly refresher courses for production and QC staff. There are no shortcuts, only direct answers to inspectors. Data integrity isn’t just a buzzword, it is ingrained in our culture by necessity. Digital backups, audit trails, and process control records are core to passing every compliance challenge.
End users, from major pharmaceutical companies to smaller compounding pharmacies, have their own requirements. Some ask for lower particle size distribution, others for fewer residual solvents, and a few want full traceability documentation for every supply chain node. We adapt by offering selectable batch release criteria, keeping analytical flexibility to include both common industry methods and client-specified protocols. For example, one customer from Europe insisted on an additional chiral purity test before accepting our lot, so we incorporated that into our QC suite.
Stakeholder feedback leads directly to process improvement. If a customer rejects a lot for flowability, we review our drying and sieving protocols or bring in particle engineering specialists. Water content issues prompt us to revisit our drying cycle, fine-tune in-process sampling, and sometimes adjust vacuum drying pressures. Each adjustment teaches the team more than a dozen checklists ever could. This ongoing feedback loop lets us ship more reliable product to markets with different needs.
Moving Propranolol Hydrochloride from our plant to clients around the world presents its own complications. APIs are sensitive to both physical and regulatory risks — high temperatures during summer shipping can affect product integrity, and customs delays seem inevitable in certain ports. Maintaining the chain of custody and preserving product quality through unforeseen shipping setbacks mean every drum gets logged, tagged, and accompanied by stability data packs.
Logistics teams plan for worst-case scenarios. We routinely test samples pulled from drums that have spent weeks in high-humidity harbors, monitoring for changes in purity, potency, and color. Our production and QA departments collaborate to ensure response teams jump on any reports of outer drum damage or delays. This level of preparation didn’t just happen overnight — every year, lessons learned from client complaints, audit findings, and market recalls cycle back into revised SOPs.
Batch failures are painful, not just in lost materials and time, but in the learning curve they force us up. We have seen failures emerge from raw material inconsistency, process drift, incomplete filtration, and sub-optimal drying. Early on, we lost a week’s output to a contamination event traced back to a single under-performing solvent distillation. Problems like these highlight the real cost of insufficient preventive checks or poorly defined specifications.
After each incident, the team carries out a full root-cause and implements corrective and preventive actions: training operators, tightening QC parameters, adjusting vendor qualification standards, and frequently, adapting equipment for better containment. Quality costs money up front but saves downstream — returning product to an unhappy client or facing a market recall brings reputational risk no one willingly invites. We believe transparency with clients about failure and follow-up builds more trust than hiding behind bureaucratic language.
Every day, clinics across continents dispense medications made with Propranolol Hydrochloride. The indirect responsibility weighs on the team. We hear about shortages of critical heart medications in some markets, and it’s clear that manufacturing delays or quality issues can worsen patient outcomes. Partnerships with clients only work if we promise, and deliver, supply that professionals and patients can count on.
We also have a broader commitment to environmental stewardship — properly recycling solvents, minimizing water discharge, and keeping our process yields as tight as practical. These efforts go beyond compliance checklists. Benefits flow both ways: we lower costs through improved efficiency and keep our license to operate by respecting environmental guidelines.
The lesson from producing Propranolol Hydrochloride year after year comes down to steady improvement. R&D doesn’t stop once a synthesis route works; the team refines each stage to reduce waste, cut solvents, and improve yield. Sometimes, regulatory updates require tweaks to starting materials or process flows. The investment in process automation, real-time monitoring, and data analytics wasn’t justified just by cost savings, but by the ability to pick up on drift before it impacts a whole lot.
We run internal benchmarking, comparing every batch’s analysis with historical trends. Outlier detection, both on incoming raw materials and final products, saves countless hours of remedial action down the line. These efforts make us better partners for our clients, keeping quality up and costs down.
We do not just ship a powder in a drum. Each step, from raw material qualification to final dispatch, gets attention because missed details add up quickly. Experience shows that the true test isn’t passing one lab’s quality analysis, but keeping quality consistent batch after batch, year after year. It’s about putting the work in on the front end to avoid trouble downstream — in the form of recalls, regulatory action, or, worst of all, impacts on patient health.
Staying on top of evolving formulation challenges, regulatory requirements, and market demand is never static. The manufacturing process for Propranolol Hydrochloride, as we practice it, means investing daily in people, equipment, and process knowledge. By doing so, we build the reliability that healthcare and industry trust. Our story is written one drum at a time, shaped by lessons learned, feedback received, and the continual pursuit of something better.